Unknown

Dataset Information

0

The Concilium of Information Processing Networks of Chemical Oscillators for Determining Drug Response in Patients With Multiple Myeloma.


ABSTRACT: It can be expected that medical treatments in the future will be individually tailored for each patient. Here we present a step towards personally addressed drug therapy. We consider multiple myeloma treatment with drugs: bortezomib and dexamethasone. It has been observed that these drugs are effective for some patients and do not help others. We describe a network of chemical oscillators that can help to differentiate between non-responsive and responsive patients. In our numerical simulations, we consider a network of 3 interacting oscillators described with the Oregonator model. The input information is the gene expression value for one of 15 genes measured for patients with multiple myeloma. The single-gene networks optimized on a training set containing outcomes of 239 therapies, 169 using bortezomib and 70 using dexamethasone, show up to 71% accuracy in differentiating between non-responsive and responsive patients. If the results of single-gene networks are combined into the concilium with the majority voting strategy, then the accuracy of predicting the patient's response to the therapy increases to ∼ 85%.

SUBMITTER: Bose A 

PROVIDER: S-EPMC9304651 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8318243 | biostudies-literature
| S-EPMC10811666 | biostudies-literature
| S-EPMC3398002 | biostudies-literature
| S-EPMC6198861 | biostudies-literature
| S-EPMC4652215 | biostudies-literature
| S-EPMC3033026 | biostudies-literature
| S-EPMC5694762 | biostudies-literature
| S-EPMC10212768 | biostudies-literature
| S-EPMC9386061 | biostudies-literature
| S-EPMC5496204 | biostudies-other